Harvard Bioscience (HBIO) Capital Expenditures Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -11.41% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 9.65% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -2.04% |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 61.83% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -63.39% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 10.63% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 21.73% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.30% |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | -16.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.96% |
| Dec 31, 2025 | 49.17% |
| Sep 30, 2025 | -76.48% |
| Jun 30, 2025 | -89.12% |
| Mar 31, 2025 | -20.47% |
| Dec 31, 2024 | -63.73% |
| Sep 30, 2024 | 305.53% |
| Jun 30, 2024 | 58.22% |
| Mar 31, 2024 | 187.95% |
| Dec 31, 2023 | 253.19% |
| Sep 30, 2023 | -50.90% |
| Jun 30, 2023 | 16.97% |
| Mar 31, 2023 | -52.44% |
| Dec 31, 2022 | -34.36% |
| Sep 30, 2022 | -7.92% |
| Jun 30, 2022 | 114.56% |
| Mar 31, 2022 | 211.92% |
| Dec 31, 2021 | 459.38% |
| Sep 30, 2021 | -14.89% |
| Jun 30, 2021 | -27.21% |